» Articles » PMID: 11684557

Iron Deposition in Renal Biopsy Specimens from Patients with Kidney Diseases

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2001 Oct 31
PMID 11684557
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

This study was performed to investigate the correlation between clinical parameters and grading of iron deposition in renal biopsy specimens from 102 patients with various kidney diseases. Iron deposition in renal tissues was detected by Berlin blue staining. The extent of iron staining was semiquantitatively graded as negative (Fe(-)), grade 0, or positive (Fe(+)), including faint, grade 1; moderate, grade 2; or severe, grade 3, by light microscopy. Thirty-four of 102 patients (33%) showed positive iron staining. Fe(+) patients had various renal diseases, mainly consisting of 12 patients with immunoglobulin A nephropathy and 5 patients with benign nephrosclerosis. Mean arterial pressure (MAP), serum creatinine (sCr) levels, incidence of hematuria, and urinary N-acetylbeta-D-glucosaminidase (u-NAG) levels in Fe(+) patients were significantly greater than those in Fe(-) patients, and u-NAG levels correlated positively with the extent of iron deposition. Study patients were tentatively divided into two groups according to the extent of iron deposition: group A, patients with grades 2 and 3 staining, and group B, patients with grades 0 and 1 staining. In group A, MAP, sCr level, urinary protein excretion, and the incidence of hematuria were significantly greater than in group B. Our results suggest that the amount of iron deposition in renal tissue may contribute to the progression of chronic renal disease and may be an early and sensitive indicator of renal damage in certain renal diseases.

Citing Articles

T1 mapping combined with arterial spin labeling MRI to identify renal injury in patients with liver cirrhosis.

Xie S, Chen M, Chen C, Zhao Y, Qin J, Qiu C Front Endocrinol (Lausanne). 2024; 15:1363797.

PMID: 39184137 PMC: 11341387. DOI: 10.3389/fendo.2024.1363797.


Mendelian Randomization Analysis of Systemic Iron Status and Risk of Different Types of Kidney Disease.

Zhou J, Shi W, Wu D, Wang S, Wang X, Min J Nutrients. 2024; 16(13).

PMID: 38999730 PMC: 11243746. DOI: 10.3390/nu16131978.


A Case of Renal Iron Overload Associated with Cold Agglutinin Disease Successfully Managed by Rituximab.

Taberner K, House A, Haig A, Hsia C Clin Hematol Int. 2024; 5(4):62-66.

PMID: 38817958 PMC: 10757762. DOI: 10.46989/001c.91478.


Inhibition of Indoxyl Sulfate-Induced Reactive Oxygen Species-Related Ferroptosis Alleviates Renal Cell Injury In Vitro and Chronic Kidney Disease Progression In Vivo.

Tsai L, Weng T, Chang T, Lan K, Chiang C, Liu S Antioxidants (Basel). 2023; 12(11).

PMID: 38001784 PMC: 10669521. DOI: 10.3390/antiox12111931.


Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases.

Li J, Zheng S, Fan Y, Tan K Cell Death Dis. 2023; 14(9):628.

PMID: 37739961 PMC: 10516929. DOI: 10.1038/s41419-023-06144-w.